• 제목/요약/키워드: GCS

검색결과 393건 처리시간 0.023초

Comprehensive Study of Microsatellite Instability Testing and Its Comparison With Immunohistochemistry in Gastric Cancers

  • Yujun Park;Soo Kyung Nam;Soo Hyun Seo;Kyoung Un Park;Hyeon Jeong Oh;Young Suk Park;Yun-Suhk Suh;Sang-Hoon Ahn;Do Joong Park;Hyung-Ho Kim;Hye Seung Lee
    • Journal of Gastric Cancer
    • /
    • 제23권2호
    • /
    • pp.264-274
    • /
    • 2023
  • Purpose: In this study, polymerase chain reaction (PCR)-based microsatellite instability (MSI) testing was comprehensively analyzed and compared with immunohistochemistry (IHC) for mismatch repair (MMR) protein expression in patients with gastric cancer (GC). Materials and Methods: In 5,676 GC cases, PCR-based MSI testing using five microsatellites (BAT-26, BAT-25, D5S346, D2S123, and D17S250) and IHC for MLH1 were performed. Reevaluation of MSI testing/MLH1 IHC and additional IHC for MSH2, MSH6, and PMS2 were performed in discordant/indeterminate cases. Results: Of the 5,676 cases, microsatellite stable (MSS)/MSI-low and intact MLH1 were observed in 5,082 cases (89.5%), whereas MSI-high (MSI-H) and loss of MLH1 expression were observed in 502 cases (8.8%). We re-evaluated the remaining 92 cases (1.6%) with a discordant/indeterminate status. Re-evaluation showed 1) 37 concordant cases (0.7%) (18 and 19 cases of MSI-H/MMR-deficient (dMMR) and MSS/MMR-proficient (pMMR), respectively), 2) 6 discordant cases (0.1%) (3 cases each of MSI-H/pMMR and MSS/dMMR), 3) 14 MSI indeterminate cases (0.2%) (1 case of dMMR and 13 cases of pMMR), and 4) 35 IHC indeterminate cases (0.6%) (22 and 13 cases of MSI-H and MSS, respectively). Finally, MSI-H or dMMR was observed in 549 cases (9.7%), of which 47 (0.8%) were additionally confirmed as MSI-H or dMMR by reevaluation. Sensitivity was 99.3% for MSI testing and 95.4% for MMR IHC. Conclusions: Considering the low incidence of MSI-H or dMMR, discordant/indeterminate results were occasionally identified in GCs, in which case complementary testing is required. These findings could help improve the accuracy of MSI/MMR testing in daily practice.

Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea

  • Moonki Hong;Mingee Choi;JiHyun Lee;Kyoo Hyun Kim;Hyunwook Kim;Choong-Kun Lee;Hyo Song Kim;Sun Young Rha;Gyu Young Pih;Yoon Jin Choi;Da Hyun Jung;Jun Chul Park;Sung Kwan Shin;Sang Kil Lee;Yong Chan Lee;Minah Cho;Yoo Min Kim;Hyoung-Il Kim;Jae-Ho Cheong;Woo Jin Hyung;Jaeyong Shin;Minkyu Jung
    • Journal of Gastric Cancer
    • /
    • 제23권4호
    • /
    • pp.574-583
    • /
    • 2023
  • Purpose: Gastric cancer (GC) is among the most prevalent and fatal cancers worldwide. National cancer screening programs in countries with high incidences of this disease provide medical aid beneficiaries with free-of-charge screening involving upper endoscopy to detect early-stage GC. However, the coronavirus disease 2019 (COVID-19) pandemic has caused major disruptions to routine healthcare access. Thus, this study aimed to assess the impact of COVID-19 on the diagnosis, overall incidence, and stage distribution of GC. Materials and Methods: We identified patients in our hospital cancer registry who were diagnosed with GC between January 2018 and December 2021 and compared the cancer stage at diagnosis before and during the COVID-19 pandemic. Subgroup analyses were conducted according to age and sex. The years 2018 and 2019 were defined as the "before COVID" period, and the years 2020 and 2021 as the "during COVID" period. Results: Overall, 10,875 patients were evaluated; 6,535 and 4,340 patients were diagnosed before and during the COVID-19 period, respectively. The number of diagnoses was lower during the COVID-19 pandemic (189 patients/month vs. 264 patients/month) than before it. Notably, the proportion of patients with stages 3 or 4 GC in 2021 was higher among men and patients aged ≥40 years. Conclusions: During the COVID-19 pandemic, the overall number of GC diagnoses decreased significantly in a single institute. Moreover, GCs were in more advanced stages at the time of diagnosis. Further studies are required to elucidate the relationship between the COVID-19 pandemic and the delay in the detection of GC worldwide.

흉부외상에 의한 심장손상 (Cardiac Injury due to Thoracic Trauma)

  • 김한용;김명영;박재홍;최창석;황상원
    • Journal of Chest Surgery
    • /
    • 제40권12호
    • /
    • pp.831-836
    • /
    • 2007
  • 배경: 심장 손상은 외상으로 사망한 환자에서 가장 많이 간과되는 손상이다. 둔상이나 관통상으로 생존하는 환자는 드물며 그리고 발생률은 아직 명확하지가 않다. 많은 수의 환자에서 긴급 또는 응급수술을 요하며 또한 사망률이 매우 높다. 대상 및 방법: 1997년 2월부터 2005년 12월까지 흉부외상으로 심장손상을 입은 응급 흉부 절개술을 한 26명의 환자를 후향적으로 조사하였다. 결과: 남자가 17명, 여자가 9명이고 평균나이는 $45.3{\pm}16.2$세($17{\sim}80$세)였다. 13명(50%) 환자는 자동차 사고, 5명(19%)의 환자는 오토바이사고로 손상을 입었다. 6명(23%)의 환자는 칼에 의해, 2명(8%)의 환자는 작업 중 높은 곳에서 떨어져서 손상을 받았다. 손상 받은 심장은 우심방 12예(46%), 좌심방 1예(4%), 우심실 5예(19%), 좌심실5예(19%) 그리고 두 곳의 심장손상이 2예(7%)였다. 진단은 12예의 환자에서는 컴퓨터 단층촬영으로, 14예의 환자는 초음파를 이용하여 진단하였다. 입원에서 수술실까지 걸린 시간은 평균$89.2{\pm}86.7$분($10{\sim}335$)이었고, 평균 진단시간은 $51.3{\pm}13.6$분(5-280)이었다. 외상인자로 개정 외상 계수, 글라스고우 혼수 계수의 평균이 $6.7{\pm}0.8,\;12.8{\pm}2.8$이었다. 사망률은 12%였다. 결론: 심장손상으로 인한 사망률은 매우 높다. 높은 관심과, 적극적이고 신속한 진단, 그리고 즉각적이고 적절한 외과적인 치료가 환자의 생존율 높일 수 있다.